From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift

被引：26

作者：

Kim, JY

Mukherjee, JS

Rich, ML

Mate, K

Bayona, J

Becerra, MC

机构：

[1] Harvard Univ, Sch Med, Dept Social Med, Program Infect Dis & Social Change, Boston, MA 02115 USA

[2] Socios En Salud Sucursal Peru, Lima, Peru

[3] Partners Hlth, Boston, MA USA

来源：

TUBERCULOSIS | 2003年 / 83卷 / 1-3期

关键词：

D O I：

10.1016/S1472-9792(02)00078-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This review examines the paradigm shift around multidrug-resistant tuberculosis (MDR-TB). This shift has centered largely on the activities of institutions participating in the World Health Organization's Working Group on DOTS-Plus for MDR-TB. We review the important milestones since 1995, namely, the emergence of new evidence, the construction of new mechanisms, and the building of consensus to support new policy guidelines. This paper offers a case study of the construction of a model of good global governance that-if the opportunity is taken-can improve access to effective TB care through improving and helping to expand the WHO-recommended DOTS strategy. (C) 2003 Elsevier Science Ltd. All rights reserved.

引用

页码：59 / 65

页数：7

共 47 条

[1]

[Anonymous], WORLD MENTAL HLTH CA

[2]

Bastian I, 2000, B WORLD HEALTH ORGAN, V78, P238

[3]

BAYONA J, IN PRESS CONTACT INV

[4]

*CDCP, 1999, MMWR-MORBID MORTAL W, V48, P661